Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-0775-2025

Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 6), Product Code 35700BAX Recall

Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 6), Product Code 35700BAX

FDA recall Class II

Ongoing

FDA lists this Class II recall for Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 6), Product Code 35700BAX. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-0775-2025
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Nov 19, 2024
FDA report date
Jan 8, 2025
Quantity in commerce
1 units
Distribution
See key details
FDA cause
Process control

What is being recalled?

Baxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 6), Product Code 35700BAX

Affected model & UDI checker

Search the exact identifiers published for Z-0775-2025.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
Not specifiedBaxter SIGMA Spectrum Infusion Pump with Master Drug Library (Version 6), Product Code 35700BAXCheck source notice00085412091570
FDA code information

GTIN 00085412091570; Serial Number: 779515

View the original FDA recall notice

Why was this product recalled?

Devices were identified as released after repair without full testing being performed, which includes flow testing.

What actions did Baxter Healthcare Corporation take?

Customers were contacted via telephone beginning 11/19/24. Baxter Healthcare is calling to notify you of a potential issue with the Spectrum infusion pump. One of your devices has been identified as released after repair without full testing being performed, which includes flow testing. Baxter is requesting the return of the impacted infusion pump to perform all tests required and confirm that the infusion pump performs as expected. As part of this process, we need to make you aware of the potential hazard associated with flow related issues. Flow issues may cause excessive therapy, free-flow condition, insufficient therapy or interruption of therapy. These may lead to serious adverse health consequences, including permanent injury and death. Send signed form to Global CORP Service Quality Field Actions [email protected]

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology